Back to search
Infection by Streptococcus Group B
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Infection by Streptococcus Group B trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Infection by Streptococcus Group B trials you may qualify forTo assess the safety and tolerability of IVT GBS-06 vaccine administered as a single-dose regimen, at three dosage levels in healthy, non-pregnant, adult women…
The main objective of this study : Demonstrate that GBS (group B streptococci) "ST-17" colonize and persist to 60 days twice in the digestive tract of newborns…
This is an open-label randomized control trial and feasibility study designed to determine the feasibility of a larger RCT in our setting that would examine pre…
Part A: The primary objective is to evaluate the safety and tolerability of a potential vaccine against Group B streptococcus. Part B: To evaluate the long ter…
The study investigated the immune response induced by the Group B streptococcus vaccine in healthy pregnant women. In addition, the study investigated the amoun…